Wickramasinghe, C.; Kim, S.; Jiang, Y.; Bao, X.; Yue, Y.; Jiang, J.; Hong, A.; Sanai, N.; Li, J.
Population Pharmacokinetic Modeling of Total and Unbound Pamiparib in Glioblastoma Patients: Insights into Drug Disposition and Dosing Optimization. Pharmaceutics 2025, 17, 524.
https://doi.org/10.3390/pharmaceutics17040524
AMA Style
Wickramasinghe C, Kim S, Jiang Y, Bao X, Yue Y, Jiang J, Hong A, Sanai N, Li J.
Population Pharmacokinetic Modeling of Total and Unbound Pamiparib in Glioblastoma Patients: Insights into Drug Disposition and Dosing Optimization. Pharmaceutics. 2025; 17(4):524.
https://doi.org/10.3390/pharmaceutics17040524
Chicago/Turabian Style
Wickramasinghe, Charuka, Seongho Kim, Yuanyuan Jiang, Xun Bao, Yang Yue, Jun Jiang, Amy Hong, Nader Sanai, and Jing Li.
2025. "Population Pharmacokinetic Modeling of Total and Unbound Pamiparib in Glioblastoma Patients: Insights into Drug Disposition and Dosing Optimization" Pharmaceutics 17, no. 4: 524.
https://doi.org/10.3390/pharmaceutics17040524
APA Style
Wickramasinghe, C., Kim, S., Jiang, Y., Bao, X., Yue, Y., Jiang, J., Hong, A., Sanai, N., & Li, J.
(2025). Population Pharmacokinetic Modeling of Total and Unbound Pamiparib in Glioblastoma Patients: Insights into Drug Disposition and Dosing Optimization. Pharmaceutics, 17(4), 524.
https://doi.org/10.3390/pharmaceutics17040524
